TABLE 1 Clinical, Pathologic, and Genetic Characteristics of Tuberous Sclerosis Complex–Associated Clear Cell Renal Carcinomas
Patient No. | Sex | VHL Mutation | 3p LOH | Size (cm)a | Stage | Grade | Angiomyolipomasb | Cystsb | Recurrencec (Time of Follow-Up) |
|---|---|---|---|---|---|---|---|---|---|
120 | F | No | No | 2.5 | III | G4 | No | Yes | No, 1 yr |
353 | F | No | No | 13 | II | G2 | Yes | No | Not available |
354 | M | No | No | 3.5 | I | G4 | Yes | Yes | No, 2 yr |
618 | F | No | No | 1.8 | I | G1 | Yes | Yes | No, 1 yr |
622 | F | No | No | 4 | I | G3 | No | Yes | No, 1 yr |
628 | M | No | No | 3 | I | G2 | Yes | Yes | No, 2 yr |